# A Study To Determine The Effect Of SB-480848 On Asthma

> **NCT00368576** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 67 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** SB 480848, tablets

## Key facts

- **NCT ID:** NCT00368576
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368576, "A Study To Determine The Effect Of SB-480848 On Asthma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00368576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*